Trial Profile
The Comparison Between Clinical and Paraclinical Effect of Iminoral [ciclosporin] Vs Neoral [ciclosporin] in Prevention of Acute Rejection in the First Year Afer Transplantation in De Novo Renal Transplant Patients
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 09 Nov 2021
Price :
$35
*
At a glance
- Drugs Ciclosporin (Primary)
- Indications Renal transplant rejection
- Focus Therapeutic Use
- 30 Oct 2009 Actual end date (1 Oct 2009) added as reported by ClinicalTrials.gov.
- 30 Oct 2009 Actual patient number (208) added as reported by ClinicalTrials.gov.
- 30 Oct 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov.